Multiple Sclerosis (MS): Clinical Trials

4 trials for Multiple Sclerosis (MS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Multiple Sclerosis (MS): new trials by email Literature Review of Multiple Sclerosis (MS) trials Research Report on Multiple Sclerosis (MS)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)
Data Collection - Multiple Sclerosis (MS)
Phase 4CompletedEMD Serono Research & Development Institute, Inc.6622019-08-152023-10-31
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Alemtuzumab - Multiple Sclerosis (MS)
Phase 4CompletedUniversity of Texas Southwestern Medical Center92018-05-012022-02-15
Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)
Tecfidera, Placebo - Multiple Sclerosis (MS)
Phase 4CompletedUniversity of Texas Southwestern Medical Center872016-03-192022-05-11
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
H.P. Acthar Gel (repository corticotropin injection) - Multiple Sclerosis (MS)
Phase 4CompletedThe University of Texas Health Science Center, Houston252013-04-012014-09-16

Narrower conditions

Multiple Sclerosis (4)

Broader conditions

Autoimmune Diseases (4)  ·  Autoimmune Diseases of the Nervous System (4)  ·  Demyelinating Autoimmune Diseases, CNS (4)  ·  Demyelinating Diseases (4)  ·  Immune System Diseases (4)  ·  Nervous System Diseases (4)

Interventions

Adrenocorticotropic Hormone (1)  ·  Alemtuzumab (1)  ·  Data Collection (1)  ·  Dimethyl Fumarate (1)

Sponsors

University of Texas Southwestern Medical Center (2)  ·  EMD Serono Research & Development Institute, Inc. (1)  ·  The University of Texas Health Science Center, Houston (1)

Countries

United States (4)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Italy (1)  ·  Lebanon (1)

Top investigators

Darin T Okuda, MD (1)  ·  Olaf Stuve, M.D., Ph.D. (1)  ·  Staley A. Brod, MD (1)

Results publications

PMID 19073949, PMID 36062026, PMID 36401339, PMID 37012898

NIH funding

2019 (1)